Pilot--Role of soy isoflavones in treatment of carcinomas
$65,390P01FY2002ESNIH
University Of Missouri-Columbia, Columbia MO
Investigators
Linked publications & trials
Paper 26096188Paper 22753646Paper 21614156Paper 19176355Paper 17920186Paper 17589598Paper 17262709Paper 16650838Paper 16332939Paper 16237062Paper 16198475Paper 16075466Paper 16046474Paper 15955597Paper 15830335Paper 15662844Paper 15365315Paper 15255941Paper 15157104Paper 15031204Paper 15020652Paper 14738448Paper 14623498Paper 14551226Paper 12788473Paper 12470882Paper 12426949Paper 12423237Paper 12217638Paper 12163704Paper 11923588Paper 11902825Paper 11841921Paper 11334730Paper 11173986Paper 11173974Paper 11150243
Abstract
This project will examine the effect of soy isoflavones on biomarkers of tumor progression in patients with tumors of the breast, ovary, endometrium or prostate and examine long term effects on survival and recurrence and on bone metabolism, lipid profiles of heart disease.
View original record on NIH RePORTER →